Mortality due to cervical cancer, 1996-2011, Santa Catarina, Brazil
Open Access
- 1 December 2014
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 23 (4) , 836-844
Abstract
Population-based quantitative study. This study's objectives were to examine the influence of regions, age, and time on cervical cancer mortality. We analyzed cervical cancer mortality rates in the State of Santa Catarina, Brazil between 1996 and 2011. Data were obtained from the Mortality Information System from the Brazilian Ministry of Health in 2013. Data were analyzed based on descriptive epidemiology. Cervical cancer mortality rates ranged from 3.6 to 5.0/100,000 women. Rates were higher among older women, with the highest rates after the age of 70. Women's awareness regarding the importance of the Pap smear test in their health checkups may differ across ages and regions of residence. The frequency of Pap smears should change due to the trend of mortality rates observed over time.Keywords
This publication has 10 references indexed in Scilit:
- Host Responses to Infection with Human Papillomavirus2014
- Human papillomavirus: current status and issues of vaccinationArchives of Virology, 2013
- Developing role of HPV in cervical cancer preventionBMJ, 2013
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010The Journal of Infectious Diseases, 2013
- Epidemiology of cervical cancer in ColombiaColombia Medica, 2012
- Fall in Human Papillomavirus Prevalence Following a National Vaccination ProgramThe Journal of Infectious Diseases, 2012
- Screening and cervical cancer cure: population based cohort studyBMJ, 2012
- Câncer de colo do útero: mortalidade em santa catarina - Brasil, 2000 a 2009Texto & Contexto - Enfermagem, 2011
- A Política de Atenção Integral à Saúde da Mulher:SER Social, 2009
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003